2019 CYIR Finalized
36 ml/kg for at least 24h; or anuria for at least 12h) without life- threatening AKI complications, to receive early RRT (within 12h of severe AKI) or delayed RRT (after 48h of persistent AKI if no emergent indication prior). Selection of the RRT mode was at the discretion of the clinician. The trial was stopped after the second interim analysis for futility. There was no observed difference in the primary outcome of death at 90 days (58% in early strategy vs. 54% in delayed strategy group, p=0.38). Comments 1. There was no difference in 90-day mortality for early renal replacement therapy vs. delayed renal replacement therapy for patients with septic shock and severe AKI who had no immedi- ate life-threatening complications attributable to AKI. 2. 17% of patients in the delayed strategy group developed cri- teria for emergency RRT (and required RRT prior to 48h), and the mortality was higher in this subgroup (though it cannot be determined whether this was a sicker subgroup of patients and/ or whether earlier RRT would have altered the outcome). 3. In the delayed strategy group, 29% of patients did not receive RRT due to spontaneous recovery of renal function. 4. These results confirm the findings of the previously published Artificial Kidney Initiation in Kidney Injury (AKIKI) study in criti- cally ill patients, as well as a subgroup analysis of that trial of patients with septic shock or ARDS. 5. Although there are variances in the definitions used for AKI and in utilization of modes of dialysis between studies and centers, this paper adds to the literature supporting no clear benefit for early initiation of RRT for AKI in septic shock if there aren’t clear indications otherwise for a need for RRT. TRACHEAL INTUBATION OF CRITICALLY ILL ADULTS Casey JD, Janz DR, Russell DW, Vonderhaar DJ, Joffe AM, Dischert KM, Brown RM, Zouk AN, Gulati S, Heideman BE, Lester MG, Toporek AH, Bentov I, Self WH, Rice TW, Semler MW, for the PreVent Investigators and the Pragmatic Critical Care Research Group. Bag-mask Ventilation dur- ing Tracheal Intubation of Critically ill Adults. N Engl J Med 2019; 380:811-821. Summary Hypoxemia is a common ICU complication during intuba- tion and has been associated with morbidity and mortal- ity in critically ill patients. Rapid sequence intubation is intended to minimize hypoxemia by obtaining rapid onset of sedation and paralysis to limit the period of apnea prior to laryngoscopy. However, it has long been unclear whether use of positive pressure ventilation during the apneic phase after rapid sequence induction averts hypoxemia without increasing aspiration risk. This study is a multicenter, ran- domized trial examining 401 patients in 7 U.S. ICUs under- going intubation to receive ventilation with bag-mask vs. no ventilation between induction and laryngoscopy. There was a significantly lower oxygen saturation between induction and 2 minutes after tracheal intubation in the no-ventilation group (93%, IQR 81-99) vs. the bag-mask ventilation group (96%, IQR 87-99) (primary outcome, P=0.01). Severe hypoxemia (oxygen saturation <80%) was observed more frequently in the no-ventilation group (22.8%) than in the bag-mask ventilation group (10.9%) (secondary outcome, RR 0.48; 95% CI 0.3 to 0.77). There was no significant dif- ference between groups in operator-observed aspiration or incidence of a new opacity on chest radiography at 48 hours. Comments 1. This study demonstrated less hypoxia and no increased inci- dence of aspiration in critically ill patients receiving bag-mask ventilation compared to those receiving no intubation after induction and prior to laryngoscopy. 2. Management prior to induction was at the discretion of the clinician, and more patients in the bag-mask ventilation group received bag-mask ventilation than did the no-ventilation group prior to induction (39.7% vs. 10.9%; relative risk=3.65; 95% CI=2.37- 5.60). 3. Patients were excluded from the trial if the treating clinician felt that the patient had an indication for ventilation between induc- tion and laryngoscopy (e.g., severe hypoxemia, severe acide- mia) or had a contraindication for ventilation (e.g., increased aspiration risk from vomiting, hematemesis, hemoptysis). 4. This trial was performed solely in the ICU (with nearly 50% of patients having sepsis or septic shock and nearly 60% of patients having hypoxemic respiratory failure as the indications for intubation) and may not be applicable to patients in non-ICU settings. 5. While the benefit-risk ratio of bag-mask ventilation might not favor all-comers (e.g., healthy patients who can be fully pre- oxygenated and those at high risk for aspiration), bag-mask ventilation appears likely to benefit critically ill patients at high risk for rapid desaturation and who also are likely to be poorly tolerant of severe hypoxemia. GUIDING RESUSCITATION IN SEPTIC SHOCK Hernández G, Ospina-Tascón GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, Friedman G, Castro R, Alegría L, Teboul JL, Cecconi M, Ferri G, Jibaja M, Pairumani R, Fernández P, Barahona D, Granda-Luna V, Cavalcanti AB, Bakker J; ANDROMEDA-SHOCK Investigators and the Latin America Intensive Care Network (LIVEN). Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients with Septic Shock. JAMA 2019 ; 321: 654-664. Summary Guided fluid resuscitation in septic shock is challenging, and while there is not universal agreement on the best GENERAL CRITICAL CARE
Made with FlippingBook
RkJQdWJsaXNoZXIy MTM1ODMw